XML 64 R53.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stock Compensation Plans (Tables)
12 Months Ended
Dec. 31, 2023
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Summary of Stock Option Activity

The following table summarizes the activity related to options during 2023:

 

 

 

Options

 

 

Weighted
Average
Exercise
Price

 

 

Weighted
Average
Remaining
Contractual
Term (Years)

 

 

Aggregate
Intrinsic
Value
(In millions)

 

Outstanding at January 1

 

 

5,927,398

 

 

$

17.20

 

 

 

 

 

 

 

Options granted

 

 

 

 

 

 

 

 

 

 

 

 

Options exercised

 

 

(329,824

)

 

 

10.12

 

 

 

 

 

$

1.0

 

Options expired

 

 

(315,118

)

 

 

15.69

 

 

 

 

 

 

 

Options cancelled

 

 

(217,641

)

 

 

17.48

 

 

 

 

 

 

 

Outstanding at December 31

 

 

5,064,815

 

 

 

17.74

 

 

 

4.5

 

 

 

13.1

 

Vested and expected to vest at December 31

 

 

5,052,481

 

 

 

17.76

 

 

 

4.5

 

 

 

13.0

 

Exercisable at December 31

 

 

3,861,080

 

 

 

20.12

 

 

 

3.9

 

 

 

8.0

 

Available for grant at December 31

 

 

18,710,713

 

 

 

 

 

 

 

 

 

 

Significant Options Groups Outstanding

Significant option groups outstanding at December 31, 2023 and related weighted average exercise price and remaining contractual term information follows:

Grant Date

 

Options
Outstanding

 

 

Options
Exercisable

 

 

Exercise
Price

 

 

Remaining
Contractual
Term (Years)

 

2/25/2020

 

 

3,110,848

 

 

 

1,907,360

 

 

$

10.12

 

 

 

6.16

 

2/27/2017

 

 

511,087

 

 

 

511,087

 

 

 

35.26

 

 

 

3.16

 

2/22/2016

 

 

492,706

 

 

 

492,706

 

 

 

29.90

 

 

 

2.15

 

2/23/2015

 

 

444,806

 

 

 

444,806

 

 

 

27.16

 

 

 

1.15

 

2/24/2014

 

 

338,440

 

 

 

338,440

 

 

 

26.44

 

 

 

0.15

 

All Other (1)

 

 

166,928

 

 

 

166,681

 

 

 

 

 

 

 

 

 

 

5,064,815

 

 

 

3,861,080

 

 

 

 

 

 

 

 

(1)
Options in the “All Other” category had exercise prices ranging from $22.27 to $32.72. The weighted average exercise price for options outstanding and exercisable in that category was $27.61 for both, while the remaining weighted average contractual term was 1.4 years for both.
Stock-based Compensation Expense and Cash Activity

Stock-based compensation expense, cash payments made to settle SARs and cash received from the exercise of stock options follows:

 

 

 

 

 

 

 

 

 

(In millions)

 

2023

 

 

2022

 

 

2021

 

Stock-based compensation expense recognized

 

$

19

 

 

$

14

 

 

$

36

 

Tax benefit

 

 

(4

)

 

 

(3

)

 

 

(8

)

After-tax stock-based compensation expense

 

$

15

 

 

$

11

 

 

$

28

 

Cash payments to settle SARs

 

$

 

 

$

 

 

$

 

Cash received from stock option exercises

 

$

3

 

 

$

1

 

 

$

26

 

Performance Share Units  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Nonvested Share Activity

The following table summarizes the activity related to performance share units during 2023:

 

 

Units

 

 

Weighted
Average
Grant Date
Fair Value

 

Unvested at January 1

 

 

663,690

 

 

$

19.43

 

Units granted

 

 

381,169

 

 

 

11.48

 

Units vested

 

 

(336,402

)

 

 

12.85

 

Units forfeited

 

 

 

 

 

 

Unvested at December 31

 

 

708,457

 

 

 

14.69

 

Restricted Stock Units  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Nonvested Share Activity

The following table summarizes the activity related to restricted stock units during 2023:

 

 

Units

 

 

Weighted
Average
Grant Date
Fair Value

 

Unvested at January 1

 

 

1,374,608

 

 

$

12.95

 

Units granted

 

 

1,361,432

 

 

 

11.84

 

Units vested

 

 

(1,270,023

)

 

 

11.03

 

Units forfeited

 

 

(63,887

)

 

 

13.10

 

Unvested at December 31

 

 

1,402,131

 

 

 

13.60

 

Units vested but not released

 

 

1,884,258

 

 

 

12.24

 

Outstanding at December 31

 

 

3,286,389

 

 

 

14.10